Cardio Diagnostics Holdings Inc (CDIOW) is an innovative player in the medical technology industry, dedicated to revolutionizing cardiovascular care through cutting-edge diagnostic solutions. By leveraging proprietary algorithms and advanced genetic testing, the company significantly improves the precision of cardiovascular risk assessments, facilitating tailored patient management strategies. With its strong emphasis on data analytics and genomics, Cardio Diagnostics is strategically positioned to meet the increasing demand for precision medicine, promising enhanced clinical outcomes. As the healthcare landscape continues to evolve, the company's commitment to advancing cardiovascular health positions it for notable growth and impact in the sector.
| Revenue (TTM) | 16,560 |
| Gross Profit (TTM) | 16,560 |
| EBITDA | $-6.27M |
| Operating Margin | -66598.00% |
| Return on Equity | -65.60% |
| Return on Assets | -38.00% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $3.82 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 185.10% |
| Shares Outstanding | 0 |
| Float | $2.83M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting